Development and Feasibility of a Digital Acceptance and Commitment Therapy–Based Intervention for Generalized Anxiety Disorder: Pilot Acceptability Study

Abstract

Background Generalized anxiety disorder (GAD) is characterized by excessive worry that is difficult to control and has high comorbidity with mood disorders including depression. Individuals experience long wait times for diagnosis and often face accessibility barriers to treatment. There is a need for a digital solution that is accessible and acceptable to those with GAD. Objective This paper aims to describe the development of a digital intervention prototype of acceptance and commitment therapy (ACT) for GAD that sits within an existing well-being app platform, BioBase. A pilot feasibility study evaluating acceptability and usability is conducted in a sample of adults with a diagnosis of GAD, self-referred to the study. Methods Phase 1 applied the person-based approach (creation of guiding principles, intervention design objectives, and the key intervention features). In Phase 2 participants received the app-based therapeutic and paired wearable for 2 weeks. Self-report questionnaires were obtained at baseline and posttreatment. The primary outcome was psychological flexibility (Acceptance and Action Questionnaire-II [AAQ-II]) as this is the aim of ACT. Mental well-being (Warwick-Edinburgh Mental Well-being Scale [WEMWBS]) and symptoms of anxiety (7-item Generalized Anxiety Disorder Assessment [GAD-7]) and depression (9-item Patient Health Questionnaire [PHQ-9]) were also assessed. Posttreatment usability was assessed via self-report measures (System Usability Scale [SUS]) in addition to interviews that further explored feasibility of the digital intervention in this sample. Results The app-based therapeutic was well received. Of 13 participants, 10 (77%) completed the treatment. Results show a high usability rating (83.5). Participants found the digital intervention to be relevant, useful, and helpful in managing their anxiety. Participants had lower anxiety (d=0.69) and depression (d=0.84) scores at exit, and these differences were significantly different from baseline (P=.03 and .008 for GAD-7 and PHQ-9, respectively). Participants had higher psychological flexibility and well-being scores at exit, although these were not significantly different from baseline (P=.11 and .55 for AAQ-II and WEMWBS, respectively). Conclusions This ACT prototype within BioBase is an acceptable and feasible digital intervention in reducing symptoms of anxiety and depression. This study suggests that this intervention warrants a larger feasibility study in adults with GAD.

Experience of symptom control, anxiety and associating factors in a palliative care unit evaluated with Support Team Assessment Schedule Japanese version

“…Regarding the observation period required for symptom control, although effects of opioids against dyspnea can be evaluated within some hours to 2 days 40 , 41 , 14 days are necessary for opioid rotation against cancer pain treatment 42 . A 2-week period is also applied in some studies evaluating transitional changes of anxiety 43 , 44 . Considering also the mean and median hospital stay of the participants in addition, data for STAS-J after 2 weeks of admission were collected again to assess their transitional change.…”

Effectiveness of Telehealth Acceptance and Commitment Therapy for Generalized Anxiety Disorder During the COVID-19 Pandemic: Protocol for a Systematic Review and Meta-Analysis

“…Evidence indicates that telehealth ACT can be a feasible and potentially e cacious treatment for GAD [28]. However, there is currently no meta-analysis on telehealth ACT intervention for patients with GAD.…”

Combining AI and human support in mental health: a digital intervention with comparable effectiveness to human-delivered care

“…This approach encourages individuals to accept their thoughts and feelings committing to actions aligned with their values. There is a growing body of evidence indicating that ACT demonstrates comparable effectiveness to other forms of CBT for anxiety disorders (59)(60)(61), and has been shown to be acceptable and engaging within a digital program for GAD (62,63).…”